Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76076 - 76100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sulindac	Approved Investigational	DCN	1634	downregulated	Sulindac results in decreased expression of DCN mRNA	12q21.33	A24352
Sulindac	Approved Investigational	DDIT3	1649	upregulated	Sulindac results in increased expression of DDIT3 mRNA	12q13.3	A22800
Sulindac	Approved Investigational	DGCR14	8220	upregulated	Sulindac results in increased expression of DGCR14 mRNA	22q11.21	A20927
Sulindac	Approved Investigational	DPYS	1807	upregulated	Sulindac results in increased expression of DPYS mRNA	8q22.3	A20927
Sulindac	Approved Investigational	EHMT2	10919	downregulated	Sulindac results in decreased expression of EHMT2 mRNA	6p21.33	A20927
Sulindac	Approved Investigational	ERCC5	2073	downregulated	Sulindac results in decreased expression of ERCC5 mRNA	13q33.1	A20927
Sulindac	Approved Investigational	ETS1	2113	upregulated	Sulindac results in increased expression of ETS1 mRNA	11q24.3	A20927
Sulindac	Approved Investigational	FBXO42	54455	upregulated	Sulindac results in increased expression of FBXO42 mRNA	1p36.13	A20927
Sulindac	Approved Investigational	FHL2	2274	upregulated	Sulindac results in increased expression of FHL2 mRNA	2q12.2	A20927
Sulindac	Approved Investigational	FTH1	2495	upregulated	Sulindac results in increased expression of FTH1 mRNA	11q12.3	A24351
Sulindac	Approved Investigational	GADD45A	1647	upregulated	Sulindac results in increased expression of GADD45A mRNA	1p31.3	A20927
Sulindac	Approved Investigational	GCNT1	2650	upregulated	Sulindac results in increased expression of GCNT1 mRNA	9q21.13	A24351
Sulindac	Approved Investigational	GDF15	9518	upregulated	Sulindac results in increased expression of GDF15 mRNA	19p13.11	A20927
Sulindac	Approved Investigational	GRB10	2887	upregulated	Sulindac results in increased expression of GRB10 mRNA	7p12.1	A20927
Sulindac	Approved Investigational	GTF2B	2959	upregulated	Sulindac results in increased expression of GTF2B mRNA	1p22.2	A20927
Sulindac	Approved Investigational	HERPUD1	9709	upregulated	Sulindac results in increased expression of HERPUD1 mRNA	16q13	A24351
Sulindac	Approved Investigational	HIF1A	3091	downregulated	Sulindac analog results in decreased expression of HIF1A mRNA	14q23.2	A23447
Sulindac	Approved Investigational	HIST2H4B	554313	upregulated	Sulindac results in increased expression of HIST2H4B mRNA	1q21.2	A20927
Sulindac	Approved Investigational	HLCS	3141	downregulated	Sulindac results in decreased expression of HLCS mRNA	21q22.13	A20927
Sulindac	Approved Investigational	HMMR	3161	downregulated	Sulindac results in decreased expression of HMMR mRNA	5q34	A20927
Sulindac	Approved Investigational	HSPA7	3311	upregulated	Sulindac results in increased expression of HSPA7 mRNA	1q23.3	A20949
Sulindac	Approved Investigational	IL1B	3553	downregulated	Sulindac results in decreased expression of IL1B mRNA	2q14.1	A20949
Sulindac	Approved Investigational	INPP5E	56623	upregulated	Sulindac results in increased expression of INPP5E mRNA	9q34.3	A20927
Sulindac	Approved Investigational	ITGA2	3673	upregulated	Sulindac results in increased expression of ITGA2 mRNA	5q11.2	A20927
Sulindac	Approved Investigational	JUND	3727	upregulated	Sulindac results in increased expression of JUND mRNA	19p13.11	A20927

Displaying entries 76076 - 76100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability